Performance Evaluation of the MyT4 Technology for Determining ART Eligibility
PLos ONE; 11 (10), 2016
Background In resource-limited countries, CD4 T-cell (CD4) testing continues to be used for determining antiretroviral therapy (ART) initiation eligibility and opportunistic infection monitoring. To support expanded access to CD4 testing, simple and robust technologies are necessary. We conducted this st...